Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...

Breast cancer screening has long been a target use case for artificial intelligence (AI). Developments in computational power ...

Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company delivering on-demand digital and ...

Please provide your email address to receive an email when new articles are posted on . Surveillance led to detection of smaller tumors among patients at high risk for pancreatic cancer. Individuals ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance data for its blood-based colorectal cancer ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company ...

NEW YORK, Jan. 24, 2024 /PRNewswire/ -- S&P Global Market Intelligence, a provider of information services and solutions to global markets, today announced an enhancement of its entity due diligence ...

Please provide your email address to receive an email when new articles are posted on . Over 80% of people at high risk for lung cancer were unaware of screening or had not discussed it with a doctor.

MELVILLE, N.Y.--(BUSINESS WIRE)-- Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company ...